FORMAT: Online Enduring CME Webcast
RELEASE DATE: July 15, 2021
EXPIRATION DATE: July 31, 2022
MAXIMUM CREDITS: 1.0 AMA PRA Category 1 Credit™
CLICK BELOW TO PROCEED TO PROGRAM
Learning Method and Medium
This educational activity consists of a webcast and four (4) study questions. The participant should, in order, read the learning objectives, complete the pretest, view the webcast, answer all questions in the posttest, and complete the evaluation. To receive credit for this activity, please complete the posttest and evaluation. This educational activity should take a maximum of 1.0 hour to complete.
Activity Description and Purpose
The successful treatment of glaucoma is challenged by many factors, including patient nonadherence to topical therapies, waning efficacy of topical therapies as disease progresses, and risks associated with traditional glaucoma surgery. As a result, several new approaches have been introduced, including sustained drug-eluting devices and minimally invasive surgical procedures. The choice of intervention is not straightforward, and a nuanced, patient-centered approach to selection is needed. In this educational activity, experts will use cases and a debate-style format to explore different treatment options for a variety of patient scenarios. The desired results of this educational activity are to enable glaucoma specialists and other ophthalmologists to confidently incorporate various new treatments beyond topical drugs to improve visual outcomes for patients with glaucoma.
Instructions for Obtaining Credit
To obtain AMA PRA Category 1 Credit™ for this activity, view the webcast in its entirety, consult referenced sources as necessary, and complete the posttest and evaluation online. Upon passing with a score of 70% or higher, a certificate will be made available immediately.
This continuing medical education activity is provided by MedEdicus LLC.
This continuing medical education activity is supported through an educational grant from Allergan.